MedTrace Logo

A Prospective Observational Study of Foam Sclerotherapy .

NCT04111692 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-26

No results posted yet for this study

Summary

An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).

Conditions

  • Autosomal Dominant Polycystic Kidney
  • Renal Cyst
  • Autosomal Dominant Polycystic Liver Disease
  • Hepatic Cyst

Sponsors & Collaborators

Principal Investigators

  • Marie Hogan, MD, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-06
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04111692 on ClinicalTrials.gov